Water

Identification

Name
Water
Accession Number
DB09145
Type
Small Molecule
Groups
Approved
Description

Water (chemical formula: H2O) is a transparent fluid which forms the world's streams, lakes, oceans and rain, and is the major constituent of the fluids of organisms. As a chemical compound, a water molecule contains one oxygen and two hydrogen atoms that are connected by covalent bonds. Water is a liquid at standard ambient temperature and pressure, but it often co-exists on Earth with its solid state, ice; and gaseous state, steam (water vapor).

Structure
Thumb
Synonyms
  • Dihydrogen oxide
  • Purified water
  • Sterile water
  • Water purified
External IDs
B1217 / NSC-147337 / R-718
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Airlife Sterile Water for Inhalation USPLiquid100 %Respiratory (inhalation)Cardinal Health Medical Products And Services1990-12-312011-08-29Canada
Bacteriostatic WaterInjection, solution1 mL/mLIntramuscularRemedy Repack2013-07-032017-01-04Us
Bacteriostatic WaterInjection, solution1 mL/mLIntramuscularRemedy Repack2013-06-102017-11-08Us
Bacteriostatic WaterSolution1 mL/mLIntramuscular; Intravenous; SubcutaneousHospira, Inc.1982-10-27Not applicableUs
Bacteriostatic WaterInjection, solution1 mL/mLIntramuscular; Intravenous; SubcutaneousGeneral Injectables & Vaccines2010-08-01Not applicableUs
Bacteriostatic WaterSolution1 mL/mLIntramuscular; Intravenous; SubcutaneousRemedy Repack2017-05-09Not applicableUs
Bacteriostatic WaterInjection, solution1 mL/mLIntramuscular; Intravenous; SubcutaneousMesource Pharmaceuticals2014-07-07Not applicableUs
Bacteriostatic Water for Injection USPLiquid100 %Intramuscular; Intravenous; SubcutaneousOmega Laboratories Ltd1994-12-31Not applicableCanada
Bacteriostatic Water for Injection USPSolution100 %Intramuscular; Intravenous; SubcutaneousHospira, Inc.1952-12-31Not applicableCanada
Bacteriostatic Water for Injection USP-pre-filled SyringeLiquid99.1 %IntracavernousPfizer1996-07-30Not applicableCanada
Generic Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Sterile DiluentInjection1 mL/mLIntravenousTeva Parenteral Medicines, Inc.2008-04-23Not applicableUs
Sterile WaterInjectionIntramuscular; Intravenous; SubcutaneousFresenius Kabi2000-09-05Not applicableUs
Sterile WaterInjection, solution1 mL/mLIntramuscular; Intravenous; SubcutaneousWest Ward Pharmaceutical2015-09-03Not applicableUs
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
A-Med brand First Aid Eye and Skin-RinseSolution98.577 mL/100mLCutaneous; Ophthalmic; Topical1602041 Ontario Limited2013-11-01Not applicableUs
Aerowash Eyewash and Skin-RinseSolution98.577 mL/100mLOphthalmicAero Healthcare2015-05-01Not applicableUs
Boraqua Eye WashSolution99.05 mL/100mLOphthalmicGenuine Drugs2015-04-20Not applicableUs
Bouton Eye WashRinse98.6 mL/100mLOphthalmicAaxis Pacific2010-01-15Not applicableUs
Buffered Eye-LertLiquid98 mL/100mLOphthalmicNorth Safety Products2010-06-06Not applicableUs
CEDERROTH Emergency Eye WashLiquid.99 mL/mLOphthalmicOrkla Care Ab2013-08-23Not applicableUs
CEDERROTH Emergency Eye WashLiquid99 mL/100mLOphthalmicCederroth Ab2014-03-13Not applicableUs
Collyrium for Fresh Eyes - Eye WashSolution99.05 mL/100mLOphthalmicBauch & Lomb Incorporated2010-08-31Not applicableUs
CVS EyewashKitTopicalCVS Health2017-10-09Not applicableUs
Dorama-NeoLiquid98.4 mL/100mLOphthalmicSato Pharmaceutical1983-11-08Not applicableUs
Unapproved/Other Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
37.4Liquid99.9974 g/100mLOralJesus Glory Bio Co.,ltd.2017-08-09Not applicableUs
37.4Liquid99.9974 g/100LOralJesus Glory Bio Co.,ltd.2017-08-09Not applicableUs
Bacteriostatic WaterInjection, solution1 mg/mLIntramuscular; Intravenous; SubcutaneousFresenius Kabi2000-10-08Not applicableUs
Eye IrrigatingSolution99.05 mL/100mLOphthalmicRugby2011-10-07Not applicableUs
Eye IrrigatingSolution99.05 mL/100mLOphthalmicA S Medication Solutions2011-10-072017-06-20Us
Eye IrrigatingSolution99.05 mL/100mLOphthalmicA S Medication Solutions2011-10-072017-06-20Us
Redicare Emergency First Aid EyewashIrrigant98.3 mL/100mLIrrigation; OphthalmicRedicare Llc2017-11-10Not applicableUs
Sterile WaterInjection, solution1 mL/mLIntravenousAmerican Regent1990-09-302017-06-24Us
Sterile WaterInjection, solution1 mL/mLIntravenousAmerican Regent1990-09-30Not applicableUs
Sterile WaterSolution5 mL/5mLIntravenousGeneral Injectables & Vaccines2010-09-012017-02-14Us
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
10 Person ANSIWater + Acetaminophen + Acetylsalicylic acid + Bacitracin zinc + Benzalkonium chloride + Benzocaine + Ethanol + Ibuprofen + Lidocaine + Neomycin sulfate + Polymyxin B SulfateKitGenuine First Aid2010-04-24Not applicableUs
25 Person ANSIWater + Acetaminophen + Acetylsalicylic acid + Bacitracin zinc + Benzalkonium chloride + Benzocaine + Ethanol + Ibuprofen + Isopropyl Alcohol + Lidocaine + Neomycin sulfate + Polymyxin B SulfateKitGenuine First Aid2010-04-25Not applicableUs
50 Person ANSIWater + Acetaminophen + Acetylsalicylic acid + Bacitracin zinc + Benzalkonium chloride + Benzocaine + Ethanol + Ibuprofen + Isopropyl Alcohol + Lidocaine + Neomycin sulfate + Polymyxin B SulfateKitGenuine First Aid2010-06-02Not applicableUs
A.P.L. - Pws-liqWater (10 ml) + Chorionic Gonadotropin (Human) (10000 unit)Liquid; Powder, for solutionIntramuscularWyeth Ayerst Canada Inc.1998-11-112001-06-01Canada
ACME FIRST AID Contains 404 PIECESWater + Acetylsalicylic acid + Bacitracin zinc + Benzalkonium chloride + Benzocaine + Ethanol + Isopropyl Alcohol + Lidocaine + Neomycin sulfate + Polymyxin B SulfateKitAcme United Corporation2010-04-27Not applicableUs
Activase RT-PAWater (100 ml) + Alteplase (100 mg)Liquid; Powder, for solutionIntravenousHoffmann La Roche1996-12-31Not applicableCanada
Activase RT-PAWater (50 ml) + Alteplase (50 mg)Liquid; Powder, for solutionIntravenousHoffmann La Roche1998-04-12Not applicableCanada
Antithrombin III ImmunoWater (30 ml) + Antithrombin III human (1650 unit)Powder, for solutionIntravenousBaxter Ag1999-07-052011-10-07Canada
Antithrombin III NfWater (20 ml) + Antithrombin III human (1100 unit)Kit; Powder, for solutionIntravenousBaxalta Canada Corporation1999-07-05Not applicableCanada
Antithrombin III NfWater (10 ml) + Antithrombin III human (550 unit)Kit; Powder, for solutionIntravenousBaxalta Canada Corporation1999-07-05Not applicableCanada
Categories
UNII
059QF0KO0R
CAS number
7732-18-5
Weight
Average: 18.0153
Monoisotopic: 18.010564686
Chemical Formula
H2O
InChI Key
XLYOFNOQVPJJNP-UHFFFAOYSA-N
InChI
InChI=1S/H2O/h1H2
IUPAC Name
water
SMILES
O

Pharmacology

Indication

For diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered [FDA Label].

Structured Indications
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
  • Humans and other mammals
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Human Metabolome Database
HMDB02111
KEGG Drug
D00001
KEGG Compound
C00001
PubChem Compound
962
PubChem Substance
310265058
ChemSpider
937
ChEBI
15377
ChEMBL
CHEMBL1098659
HET
HOH
Drugs.com
Drugs.com Drug Page
Wikipedia
Water
AHFS Codes
  • 40:50.00* — Diluents
  • 52:92.00 — EENT Drugs, Miscellaneous
  • 40:36.00 — Irrigating Solutions
  • 92:92.00 — Other Miscellaneous Therapeutic Agents
PDB Entries
1a65 / 1adl / 1b0k / 1c96 / 1c97 / 1cls / 1dic / 1dmr / 1dz9 / 1ebe
show 72 more
FDA label
Download (97.6 KB)
MSDS
Download (79.7 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
0CompletedTreatmentInclusion Body Myositis (IBM)1
0RecruitingHealth Services ResearchDental Decay1
1Active Not RecruitingBasic ScienceHuman Memory / Intranasal Insulin1
1Active Not RecruitingTreatmentSickle Cell Disorders1
1CompletedNot AvailableChronic Hepatitis C Infection1
1CompletedNot AvailableHealthy Volunteers1
1CompletedBasic ScienceDisseminated Sclerosis2
1CompletedBasic ScienceHealthy Volunteers3
1CompletedPreventionFluorosis, Dental1
1CompletedTreatmentAcute and Chronic Inflammation / Autoimmune Diseases / Disorder of Pleura and Pleural Cavity / Disorder of Synovium / Felty's Syndrome / Rheumatoid Arthritis / Rheumatoid Nodules / Sjögren's Syndrome1
1CompletedTreatmentCancer, Advanced / Tumors, Solid1
1CompletedTreatmentDentist-Patient Relations1
1CompletedTreatmentPsoriasis1
1CompletedTreatmentThrombosis1
1CompletedTreatmentTumors1
1RecruitingTreatmentRheumatoid Arthritis1
1, 2Active Not RecruitingTreatmentMelanoma1
1, 2CompletedNot AvailableHealthy Volunteers1
1, 2CompletedTreatmentAdenocarcinomas / Neoplasms, Pancreatic1
1, 2CompletedTreatmentChronic Lymphocytic Leukaemia (CLL) / Small Lymphocytic Lymphoma (SLL)1
1, 2CompletedTreatmentHeadaches / Migraines1
1, 2CompletedTreatmentMelanoma1
1, 2Enrolling by InvitationTreatmentFemale Infertility Due to Diminished Ovarian Reserve1
1, 2RecruitingOtherHypercholesterolemia, Familial / Hypertriglyceridemias1
1, 2RecruitingPreventionNecrotizing Enterocolitis1
1, 2RecruitingTreatmentCarcinoma, Colorectal / Colorectal Cancers / Colorectal Tumors / Neoplasms, Colorectal1
1, 2RecruitingTreatmentMalignant Neoplasm of Pancreas Metastatic to Peritoneal Surface / Malignant Peritoneal Mesothelioma / Peritoneal Carcinomatosis1
1, 2TerminatedTreatmentRenal Cell Adenocarcinoma1
1, 2WithdrawnTreatmentDiabetes, Diabetes Mellitus Type 11
1, 2WithdrawnTreatmentMelanoma1
2Active Not RecruitingPreventionGraft Versus Host Disease (GVHD)1
2Active Not RecruitingPreventionHigh-Grade Squamous Intraepithelial Lesions / Human Papillomavirus1
2Active Not RecruitingTreatmentCutaneous Melanoma / Metastatic Melanoma1
2Active Not RecruitingTreatmentCystic Fibrosis (CF)1
2Active Not RecruitingTreatmentLupus Erythematosus, Chronic Cutaneous / Lupus Erythematosus, Cutaneous / Lupus Erythematosus, Discoid1
2Active Not RecruitingTreatmentMucocutaneous Lymph Node Syndrome1
2CompletedBasic ScienceDisseminated Sclerosis1
2CompletedSupportive CareOral Mucositis1
2CompletedTreatmentArthritis, Juvenile Rheumatoid / Uveitis1
2CompletedTreatmentDisseminated Sclerosis1
2CompletedTreatmentGraft Versus Host Disease (GVHD)1
2CompletedTreatmentHIV I Infection / Human Immunodeficiency Virus (HIV) Infections1
2CompletedTreatmentHand, Foot, and Mouth Disease1
2CompletedTreatmentHidradenitis Suppurativa (HS)2
2CompletedTreatmentHuman Immunodeficiency Virus (HIV) Infections1
2CompletedTreatmentLung Injury, Acute / Obliterative Bronchiolitis / Respiratory Distress Syndrome, Adult1
2CompletedTreatmentMultiple Myeloma (MM)1
2CompletedTreatmentPeriodontitis / Premature Birth of Newborn1
2CompletedTreatmentPersistent Knee Joint Synovitis1
2CompletedTreatmentPost-Operative Pain1
2CompletedTreatmentPsoriasis1
2CompletedTreatmentRelapsing Remitting Multiple Sclerosis (RRMS)1
2CompletedTreatmentRheumatoid Arthritis1
2CompletedTreatmentTooth Erosion1
2CompletedTreatmentUlcerative Colitis (UC)1
2RecruitingTreatmentDiabetes, Diabetes Mellitus Type 1 / Transplant, Kidney1
2RecruitingTreatmentTinea Pedis1
2SuspendedTreatmentPrimary Systemic Amyloidosis1
2TerminatedTreatmentLeukemias1
2TerminatedTreatmentMycosis Fungoides (MF) / Neoplasms, Hematologic / T-Cell Lymphomas1
2TerminatedTreatmentNephritis, Lupus1
2TerminatedTreatmentRheumatoid Arthritis1
2TerminatedTreatmentVesicular Stomatitis1
2Unknown StatusTreatmentAcute Lung Injury (ALI) / Respiratory Distress Syndrome, Adult1
2Unknown StatusTreatmentAnkylosing Spondylitis (AS)1
2Unknown StatusTreatmentSpondyloarthritis1
2WithdrawnTreatmentCancer, Advanced / Tumors, Solid1
2WithdrawnTreatmentCholestasis / Liver Diseases1
2, 3CompletedTreatmentChronic Hepatitis C Virus (HCV) Infection1
2, 3RecruitingTreatmentDrug-Induced Liver Injury1
2, 3TerminatedDiagnosticBone Cancer / Lung Cancers / Neoplasms Metastasis / Prostate Cancer1
2, 3WithdrawnPreventionNeonatal Mortality Rate / Neonatal Sepsis1
2, 3WithdrawnTreatmentChronic Idiopathic Urticaria1
3Active Not RecruitingTreatmentHypothyroxinemia1
3Active Not RecruitingTreatmentRheumatoid Arthritis1
3CompletedNot AvailableDisseminated Sclerosis2
3CompletedPreventionBreast Cancer With Low to Intermediate HER2 Expression1
3CompletedTreatmentAcute Major Bleeding / Disorders, Blood Coagulation1
3CompletedTreatmentCancer, Breast / Menopause / Painful Intercourse / Vulvodynia1
3CompletedTreatmentDisseminated Sclerosis1
3CompletedTreatmentGynecological Laparoscopy1
3CompletedTreatmentJuvenile Idiopathic Arthritis (JIA)1
3CompletedTreatmentMelanoma / Neoplasms Metastasis1
3CompletedTreatmentPain1
3CompletedTreatmentPalmoplantaris Pustulosis1
3CompletedTreatmentPlaque Psoriasis1
3CompletedTreatmentPsoriasis1
3CompletedTreatmentReversal of Coagulopathy1
3CompletedTreatmentRheumatoid Arthritis1
3RecruitingSupportive CarePain1
3RecruitingTreatmentRelapsing Remitting Multiple Sclerosis (RRMS)1
3RecruitingTreatmentSignificant Bleeding Risk1
3TerminatedTreatmentArthritis, Juvenile Rheumatoid1
3TerminatedTreatmentDisseminated Sclerosis1
3Unknown StatusTreatmentHELLP Syndrome1
3WithdrawnTreatmentGastro-intestinal Neuroendocrine Tumors1
3WithdrawnTreatmentHypertrophic Scars / Minor burns1
4Active Not RecruitingTreatmentAnkylosing Spondylitis (AS) / Inflammatory Reaction1
4CompletedNot AvailableAnkylosing Spondylitis (AS)2
4CompletedNot AvailableArthritis / Rheumatoid1
4CompletedNot AvailableDisseminated Sclerosis1
4CompletedNot AvailableFevers1
4CompletedBasic ScienceDisseminated Sclerosis1
4CompletedDiagnosticCancers1
4CompletedDiagnosticStomach Neoplasms1
4CompletedPreventionMouthwash / Oral Biofilm / Periodontitis1
4CompletedTreatmentActive Rheumatoid Arthritis / Rheumatoid Arthritis1
4CompletedTreatmentAnkylosing Spondylitis (AS)1
4CompletedTreatmentAtopic Dermatitis (AD)1
4CompletedTreatmentCesarean Section1
4CompletedTreatmentCirrhosis of the Liver / Hepatic Encephalopathy1
4CompletedTreatmentConjunctival Intraepithelial Neoplasia / Corneal Intraepithelial Neoplasia1
4CompletedTreatmentEndocrine ophthalmopathy1
4CompletedTreatmentMeconium Ileus / Very Low Birth Weight Infant1
4CompletedTreatmentMelanoma / Non-Melanoma Skin Cancer (NMSC) / Psoriasis1
4CompletedTreatmentProcedural Pain1
4CompletedTreatmentPsoriasis4
4CompletedTreatmentPsoriasis Vulgaris1
4CompletedTreatmentPsoriasis / Sleep Apnea, Obstructive1
4CompletedTreatmentPsoriatic Arthritis1
4CompletedTreatmentRespiratory-Gated Imaging Techniques1
4CompletedTreatmentRheumatoid Arthritis3
4CompletedTreatmentSmall intestinal obstruction1
4CompletedTreatmentSpondyloarthritis, Axial1
4Enrolling by InvitationTreatmentBlood Loss,Surgical / Cardiovascular Surgical Procedures / Fresh Frozen Plasma / Haemorrhage / Prothrombin Complex Concentrates1
4Not Yet RecruitingPreventionBiofilms / Oils, Essential / Periodontitis1
4Not Yet RecruitingPreventionBiofilms / Oils, Essential / Substantivity1
4Not Yet RecruitingTreatmentAnkylosing Spondylitis (AS)1
4RecruitingBasic ScienceRheumatoid Arthritis1
4RecruitingPreventionPostoperative Complications1
4RecruitingTreatmentLymphoma, T-Cell, Cutaneous / Mycosis Fungoides (MF)1
4RecruitingTreatmentPain1
4RecruitingTreatmentPain Due to Certain Specified Procedures1
4RecruitingTreatmentPancreatitis, Chronic; Diabetes; Transplant1
4RecruitingTreatmentRheumatoid Arthritis2
4TerminatedPreventionPremature Babies1
4TerminatedTreatmentAnkylosing Spondylitis (AS)1
4TerminatedTreatmentRelapsing Remitting Multiple Sclerosis (RRMS)1
4TerminatedTreatmentRheumatoid Arthritis1
4TerminatedTreatmentRheumatoid Arthritis / Vascular Inflammation1
4Unknown StatusSupportive CareNasal Surgery1
4Unknown StatusTreatmentArthritis / Rheumatoid Arthritis1
4Unknown StatusTreatmentJuvenile Idiopathic Arthritis (JIA)1
4Unknown StatusTreatmentMyocardial Infarction (MI)1
4Unknown StatusTreatmentPsoriasis1
4WithdrawnBasic ScienceRheumatoid Arthritis1
4WithdrawnPreventionAcute Kidney Injury (AKI)1
Not AvailableActive Not RecruitingNot AvailablePsoriasis1
Not AvailableCompletedNot AvailableAnkylosing Spondylitis (AS)1
Not AvailableCompletedNot AvailableAnkylosing Spondylitis (AS) / Psoriatic Arthritis / Rheumatoid Arthritis1
Not AvailableCompletedNot AvailableDisseminated Sclerosis1
Not AvailableCompletedNot AvailableDisseminated Sclerosis / Pregnancy / Prenatal Exposure Delayed Effects1
Not AvailableCompletedNot AvailableHealthy Volunteers1
Not AvailableCompletedNot AvailableHemorrhage1
Not AvailableCompletedNot AvailableJuvenile Idiopathic Arthritis (JIA)1
Not AvailableCompletedNot AvailablePregnancy1
Not AvailableCompletedNot AvailablePsoriasis / Psoriatic Arthritis / Skin Diseases, Papulosquamous1
Not AvailableCompletedNot AvailableRheumatoid Arthritis2
Not AvailableCompletedHealth Services ResearchCongenital Hypoplastic Anemia1
Not AvailableCompletedTreatmentAcquired Immune Deficiency Syndrome (AIDS) / Human Immunodeficiency Virus (HIV) Infections1
Not AvailableCompletedTreatmentChronic Daily Headache1
Not AvailableCompletedTreatmentCoronary Artery Disease / Inflammatory Reaction / Rheumatoid Arthritis1
Not AvailableCompletedTreatmentDisseminated Sclerosis1
Not AvailableCompletedTreatmentMetabolic Syndromes2
Not AvailableCompletedTreatmentPain1
Not AvailableCompletedTreatmentPsoriasis1
Not AvailableCompletedTreatmentRheumatoid Arthritis1
Not AvailableCompletedTreatmentSoft Tissue Anaesthesia1
Not AvailableEnrolling by InvitationNot AvailablePsoriasis Arthritis / Rheumatoid Arthritis1
Not AvailableRecruitingNot AvailableHemophilia1
Not AvailableRecruitingNot AvailableHemorrhage1
Not AvailableRecruitingDiagnosticDysuria / Hematuria / Recurrent Uti1
Not AvailableTerminatedNot AvailableAnkylosing Spondylitis (AS) / Rheumatoid Arthritis1
Not AvailableTerminatedPreventionBMI >30 kg/m2 / Hyperlipidemias / Hypertensive / Metabolic Syndromes / Psoriasis1
Not AvailableTerminatedPreventionInfants / Newborn Diseases1
Not AvailableUnknown StatusTreatmentWound site1
Not AvailableWithdrawnTreatmentChronic Regional Pain Syndrome / CRP1
Not AvailableWithdrawnTreatmentIntracranial Hemorrhage, Spontaneous / Intracranial Hemorrhage, Traumatic1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
LiquidOral99.9974 g/100mL
LiquidOral99.9974 g/100L
SolutionCutaneous; Ophthalmic; Topical98.577 mL/100mL
Liquid; powder, for solutionIntravenous
SolutionOphthalmic98.577 mL/100mL
LiquidRespiratory (inhalation)100 %
Kit; powder, for solutionIntravenous
Injection, solutionIntramuscular1 mL/mL
Injection, solutionIntramuscular; Intravenous; Subcutaneous1 mg/mL
Injection, solutionIntramuscular; Intravenous; Subcutaneous1 mL/mL
SolutionIntramuscular; Intravenous; Subcutaneous1 mL/mL
LiquidIntramuscular; Intravenous; Subcutaneous100 %
LiquidIntracavernous99.1 %
RinseOphthalmic98.6 mL/100mL
LiquidOphthalmic98 mL/100mL
Kit; liquid; powder, for solutionIntracavernous
LiquidOphthalmic.99 mL/mL
LiquidOphthalmic99 mL/100mL
SolutionOphthalmic99.05 mL/100mL
KitTopical
LiquidIntramuscular; Intravenous; Subcutaneous1 ml
LiquidOphthalmic98.4 mL/100mL
LiquidOphthalmic.983 mg/mL
For solutionOphthalmic14.85 mL/15mL
LiquidIrrigation999.1 mg/mL
LiquidTopical.991 mL/mL
Kit; liquid; powder, for solutionSubcutaneous
LiquidOphthalmic98.3 mL/100mL
SolutionOphthalmic986 mg/mL
LiquidOphthalmic983 mg/mL
SolutionOphthalmic991 mg/mL
Solution / dropsIntraocular980 mg/mL
SolutionOphthalmic
SolutionOphthalmic980 mg/mL
LiquidOphthalmic92.2 mL/100mL
SolutionOphthalmic14.85 mL/15mL
SolutionCutaneous; Irrigation; Ophthalmic; Topical985.77 g/1000mL
SolutionOphthalmic.98 mL/mL
Solution, concentrateCutaneous; Irrigation; Ophthalmic; Topical889.6 g/1000mL
LiquidOphthalmic232.6 mg/236mL
LiquidIntravesical
Kit; liquid; powder, for solutionIntralesional; Intramuscular; Intravenous; Subcutaneous
Liquid; powder, for solutionIntralesional; Intramuscular; Intravenous; Subcutaneous
Liquid; powder, for solutionIntralesional; Intramuscular; Subcutaneous
Kit; liquid; powder, for solutionIntravenous
Powder, for solutionIntravenous
SolutionOphthalmic.929 g/946mL
SolutionOphthalmic.983 mg/mL
Kit
Powder, for solutionIntramuscular; Intravenous
KitOphthalmic; Respiratory (inhalation); Topical
Kit; powder, for solutionIntramuscular; Subcutaneous
LiquidOphthalmic.988 mL/mL
SolutionOphthalmic929 g/946mL
LiquidOphthalmic99.1 mL/100mL
LiquidOphthalmic95.1 mL/100mL
Kit; liquid; powder, for solutionIntramuscular
Kit; liquid; powder, for solutionIntramuscular; Subcutaneous
Liquid; powder, for solutionIntramuscular; Subcutaneous
Liquid; powder, for solutionIntramuscular
Powder, for solutionIntramuscular
SolutionOphthalmic473 mL/473mL
Solution / dropsOphthalmic99.03 mL/100mL
IrrigantIrrigation; Ophthalmic98.3 mL/100mL
Solution / dropsOphthalmic99.05 mL/100mL
SolutionOphthalmic98.3 mL/100mL
SolutionOphthalmic98.5 mL/100mL
Powder, for solutionSubcutaneous
IrrigantTopical98 mL/100mL
LiquidOphthalmic98.6 mL/100mL
LiquidOphthalmic99.8 mL/100mL
Kit; powder, for solutionSubcutaneous
InjectionSubcutaneous
LiquidIntravenous
LiquidParenteral100 %
LiquidOphthalmic98.16 mL/100mL
SolutionOphthalmic.987 mL/mL
InjectionIntramuscular; Intravenous; Subcutaneous
InjectionIntramuscular; Intravenous; Subcutaneous1 mL/mL
InjectionIntravenous1 mL/mL
Injection, solutionIntramuscular; Intravenous; Subcutaneous50 mL/50mL
Injection, solutionIntravenous1 mL/mL
Injection, solutionIntravenous100 mL/100mL
Injection, solutionIntravenous1000 mL/1000mL
IrrigantIrrigation1 mL/mL
IrrigantIrrigation100 mL/100mL
LiquidIntravenous1 mL/mL
SolutionIntravenous5 mL/5mL
LiquidIntravenous
LiquidParenteral
LiquidIntramuscular; Intraperitoneal; Intravenous; Subcutaneous100 %
LiquidIntravascular1 ml
LiquidIntravenous100 %
LiquidParenteral10 ml
LiquidParenteral2 ml
SolutionIntramuscular; Intraperitoneal; Intravenous; Subcutaneous100 %
SolutionIntramuscular; Intravenous; Subcutaneous100 %
LiquidIntraperitoneal; Irrigation100 %
LiquidIntraperitoneal; Irrigation; Topical100 %
LiquidIrrigation100 %
Solution, concentrateCutaneous; Irrigation; Ophthalmic; Topical992.96 g/1000mL
LiquidOphthalmic99.05 mL/100mL
LiquidIntramuscular; Intravenous; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Liquid
Experimental Properties
PropertyValueSource
melting point (°C)0MSDS
boiling point (°C)100MSDS
water solubilityCompletely miscibleMSDS
Predicted Properties
PropertyValueSource
logP-0.65ChemAxon
pKa (Strongest Acidic)15.7ChemAxon
pKa (Strongest Basic)-1.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area25.3 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity3.7 m3·mol-1ChemAxon
Polarizability1.51 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Mass Spectrum (Electron Ionization)MSsplash10-014i-9000000000-f7ee14225b4277f6218c
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-1a741e1ffb75284635fc
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-1a741e1ffb75284635fc
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-1a741e1ffb75284635fc
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-a2a06393708ba68baab0
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-a2a06393708ba68baab0
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-a2a06393708ba68baab0
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-0006-0940000000-08a1813d85727d668cf4
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-0a4l-0980000000-5b109ff45e0e5e5051ae
1H NMR Spectrum1D NMRNot Applicable

Taxonomy

Description
This compound belongs to the class of inorganic compounds known as homogeneous other non-metal compounds. These are inorganic non-metallic compounds in which the largest atom belongs to the class of 'other non-metals'.
Kingdom
Inorganic compounds
Super Class
Homogeneous non-metal compounds
Class
Homogeneous other non-metal compounds
Sub Class
Not Available
Direct Parent
Homogeneous other non-metal compounds
Alternative Parents
Not Available
Substituents
Homogeneous other non metal
Molecular Framework
Not Available
External Descriptors
oxygen hydride, mononuclear parent hydride, inorganic hydroxy compound (CHEBI:15377) / a small molecule (WATER)

Drug created on October 01, 2015 10:19 / Updated on November 13, 2017 21:49